Welcome to the Department of Pharmaceutical Sciences


Recent Announcements:

Dr. Simberg has received a new NIH R01 for his project entitled, “Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma”

Carlos Catalano received an ABNexus award for a project with CU Boulder faculty Theodore Randolph, PhD, (Department of Chemical and Biological Engineering), for their project entitled: “Novel Antimicrobials for Multi-Drug Resistant Osteomyelitis: Bacteriophage Stabilized for Extended Release by Atomic Layer Deposition Processes”

Jen Kiser received an R01 from NIH for Alcohol biomarker PeTH and HIV prevention for her project entitled “Predictive Power of PeTH for HIV Prevention in the Long-Acting Era”

Pete Anderson received a 4-year R01 for a project entitled “Long-acting multi prevention implant for 2-year contraception and HIV PrEP”. This is to develop a POC assay for drug concentrations for an at-home test

rajesh-agarwal

Welcome to the Department of Pharmaceutical Sciences, a research-intensive department that has long ranked in the top 10% of all schools of pharmacy in both total and NIH-specific funding. Our research comprises a unique blend of basic and translational science with an emphasis on drug discovery, development, and delivery. Our faculty address real world problems with a direct impact – such as developing first in class inhibitors for colorectal cancer, tracking the ability of the SARS CoV2 spike protein to evade antibody response, and addressing toxicity in populations exposed to synthetic PFAS contaminants. To support our interdisciplinary brand of science, we host multiple centers and core facilities, and constantly invest in new and emerging technologies. For example, as part of our new Center for Drug Discovery, we recently installed high throughput screening and imaging robotics, which represent the only example of its kind between the Coasts and a once in a decade investment. As with our other centers and cores, this instrumentation is available to the Anschutz Campus, the state of Colorado, and the greater Rocky Mountain region. We also maintain multiple PhD programs, and an MS program with specialty tracks and an online option. Collectively, our researchers, faculty and staff are committed to diversity, inclusivity, and sense of community in our quest for transformational science. Please reach out to us with any questions – we look forward to hearing from you.

Raj Agarwal, PhD – Interim Chair
Manisha Patel, PhD – Vice-Chair
David Bain, PhD – Vice-Chair
David Ross, PhD – Associate Dean of Research and Graduate Studies


Upcoming Events


Research Areas


pharmaceutical biotechnology

Pharmaceutical Biotechnology

molecular-biophysics

Molecular Biophysics

molecular-toxicology

Molecular Toxicology

cancer-pharmacology

Pharmacology

clinical-translational-sciences

Clinical and Translational Sciences

drug-discovery

Drug Discovery

systems-approaches

Systems Approaches

nanomedicine-nanosafety

Nanomedicine and Nanosafety


Academic Programs


phd-pharmsci-card

PhD in Pharmaceutical Sciences

From drug discovery all the way to clinical trials, our PhD program in Pharmaceutical Sciences will give you ideal training to become an innovator. Major areas of study include pharmaceutical biotechnology, molecular biophysics, drug delivery, nanotechnology, clinical pharmaceutical sciences and medicinal chemistry.

phd-toxicology-card

PhD in Toxicology

Come join us as we find answers to pressing medical questions in areas ranging from environmental lung disease to the effects of chemical warfare agents. We’re here to help you develop independent research careers in molecular and environmental toxicology.

ms-pharmsci-card

Masters in Pharmaceutical Sciences

The multidisciplinary field of pharmaceutical sciences has seen rapid advances that are critical to the discovery and development of drugs for chronic diseases such as cancer and diabetes, and emerging threats such as new pathogens and drug resistance. By training with our experts, you’ll be on the best track to keep up with the constantly evolving field.

t32-training-program-card

T32 training program Molecular and Systems Toxicology

T32 training program in Molecular and Systems Toxicology (NIEHS T32 ES029074) is a multi-disciplinary research mentorship program centered on training in systems toxicology including genomics/epigenetics, proteomics, and metabolomics as well as molecular approaches to investigate underlying mechanisms of toxicity. 


Department News


Contact Us:

Isabella Jaramillo
Email: Isabella.Jaramillo@cuanschutz.edu  
Phone: 303.724.7263